Fig. 7From: Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic reviewThe sources of MSCs used in clinical trials to prevent or treat GVHD. BM bone marrow, UC umbilical cord, AT adipose tissue, WJ Wharton’s jelly, iPSC induced pluripotent stem cells, N/A not reportedBack to article page